MTOR and neoplasm: Among the more sensitive drugs in the high-risk group, phenformin had been shown to act as an authentic tumor disruptor, not only to maintain energy metabolism homeostasis by activating AMP-activated protein kinase (AMPK), but also as a blocker of mTOR regulatory complexes [42].